Literature DB >> 34199968

Neuro-Signals from Gut Microbiota: Perspectives for Brain Glioma.

Giuseppina D'Alessandro1,2, Clotilde Lauro1, Deborah Quaglio3, Francesca Ghirga3, Bruno Botta3, Flavia Trettel1, Cristina Limatola2,4.   

Abstract

Glioblastoma (GBM) is the most aggressive form of glioma tumor in adult brain. Among the numerous factors responsible for GBM cell proliferation and invasion, neurotransmitters such as dopamine, serotonin and glutamate can play key roles. Studies performed in mice housed in germ-free (GF) conditions demonstrated the relevance of the gut-brain axis in a number of physiological and pathological conditions. The gut-brain communication is made possible by vagal/nervous and blood/lymphatic routes and pave the way for reciprocal modulation of functions. The gut microbiota produces and consumes a wide range of molecules, including neurotransmitters (dopamine, norepinephrine, serotonin, gamma-aminobutyric acid [GABA], and glutamate) that reach their cellular targets through the bloodstream. Growing evidence in animals suggests that modulation of these neurotransmitters by the microbiota impacts host neurophysiology and behavior, and affects neural cell progenitors and glial cells, along with having effects on tumor cell growth. In this review we propose a new perspective connecting neurotransmitter modulation by gut microbiota to glioma progression.

Entities:  

Keywords:  cell proliferation; glioma; gut-brain axis; microbiota; neurotransmitters

Year:  2021        PMID: 34199968     DOI: 10.3390/cancers13112810

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  6 in total

Review 1.  Glioma and the gut-brain axis: opportunities and future perspectives.

Authors:  Antonio Dono; Jack Nickles; Ana G Rodriguez-Armendariz; Braden C McFarland; Nadim J Ajami; Leomar Y Ballester; Jennifer A Wargo; Yoshua Esquenazi
Journal:  Neurooncol Adv       Date:  2022-04-14

2.  The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study.

Authors:  Haixiao Jiang; Wei Zeng; Xiaoli Zhang; Yunlong Pei; Hengzhu Zhang; Yuping Li
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

3.  Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells.

Authors:  Aleksandra Majchrzak-Celińska; Robert Kleszcz; Anna Stasiłowicz-Krzemień; Judyta Cielecka-Piontek
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

Review 4.  Impact of Contaminants on Microbiota: Linking the Gut-Brain Axis with Neurotoxicity.

Authors:  Jordina Balaguer-Trias; Deepika Deepika; Marta Schuhmacher; Vikas Kumar
Journal:  Int J Environ Res Public Health       Date:  2022-01-26       Impact factor: 3.390

Review 5.  Neurotransmitters: Potential Targets in Glioblastoma.

Authors:  Qiqi Huang; Lishi Chen; Jianhao Liang; Qiongzhen Huang; Haitao Sun
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

6.  Bifidobacterium lactis combined with Lactobacillus plantarum inhibit glioma growth in mice through modulating PI3K/AKT pathway and gut microbiota.

Authors:  Li Wang; Sui Li; Huali Fan; Mingyu Han; Jie Xie; Junrong Du; Fu Peng
Journal:  Front Microbiol       Date:  2022-09-06       Impact factor: 6.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.